GlaxoSmithKline hit with antitrust allegations by U.K. regulators, NY Times says British regulators today formally charged GlaxoSmithKline (GSK) with conspiring with three generic drug companies to postpone the launch of a generic anti-depression drug, according to the New York Times. Reference Link
News For GSK From The Last 14 Days
Check below for free stories on GSK the last two weeks.
Ligand says partner GSK submits application for Promacta Ligand Pharmaceuticals (LGND) said its partner GlaxoSmithKline (GSK) announced today the submission of a supplemental New Drug Application to the FDA for Promacta for the treatment of cytopenias in patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.